Nutriband, Inc. (NTRB)
5.71
-0.39
(-6.39%)
USD |
NASDAQ |
Sep 09, 15:48
Nutriband Price to Book Value : 13.03 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 13.92 |
| September 04, 2026 | 13.63 |
| September 03, 2026 | 12.85 |
| September 02, 2026 | 10.73 |
| September 01, 2026 | 9.917 |
| August 31, 2026 | 9.967 |
| August 28, 2026 | 10.18 |
| August 27, 2026 | 10.54 |
| August 26, 2026 | 10.27 |
| August 25, 2026 | 11.02 |
| August 24, 2026 | 11.66 |
| August 21, 2026 | 10.65 |
| August 20, 2026 | 8.707 |
| August 19, 2026 | 8.103 |
| August 18, 2026 | 7.874 |
| August 17, 2026 | 7.372 |
| August 14, 2026 | 7.532 |
| August 13, 2026 | 7.281 |
| August 12, 2026 | 7.018 |
| August 11, 2026 | 7.258 |
| August 10, 2026 | 7.167 |
| August 07, 2026 | 7.098 |
| August 06, 2026 | 6.653 |
| August 05, 2026 | 6.573 |
| August 04, 2026 | 6.505 |
| Date | Value |
|---|---|
| August 03, 2026 | 6.414 |
| July 31, 2026 | 6.505 |
| July 30, 2026 | 5.909 |
| July 29, 2026 | 5.848 |
| July 28, 2026 | 6.000 |
| July 27, 2026 | 6.051 |
| July 24, 2026 | 6.051 |
| July 23, 2026 | 5.949 |
| July 22, 2026 | 6.193 |
| July 21, 2026 | 6.254 |
| July 20, 2026 | 6.254 |
| July 17, 2026 | 6.315 |
| July 16, 2026 | 6.355 |
| July 15, 2026 | 6.193 |
| July 14, 2026 | 6.051 |
| July 13, 2026 | 5.970 |
| July 10, 2026 | 6.010 |
| July 09, 2026 | 6.274 |
| July 08, 2026 | 6.213 |
| July 07, 2026 | 6.152 |
| July 06, 2026 | 6.376 |
| July 02, 2026 | 6.213 |
| July 01, 2026 | 6.274 |
| June 30, 2026 | 6.477 |
| June 29, 2026 | 6.518 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.707 |
| Corcept Therapeutics, Inc. | 17.58 |
| Veru, Inc. | 1.514 |
| Johnson & Johnson | 7.603 |
| Eli Lilly & Co. | 31.28 |
Price to Book Value Related Metrics
| PS Ratio | 42.82 |
| Price | 5.71 |
| Earnings Yield | -10.08% |
| Market Cap | 69.41M |